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We contrasted the protein kinase activities of pp6Ov.-r(, the transforming protein
of Rous sarcoma virus, and its normal cellular homolog pp60c--"' with respect to
inhibition by Pl,P4-di(adenosine-5')tetraphosphate by using the immune complex
protein kinase assay. The concentration of Pl'P4-di(adenosine-5')tetraphosphate
required for 50% inhibition of pp60v-,r, kinase (1 FLM) was found to be significantly
lower than that required for inhibition of pp60c-'' kinase (46 JIM). Viral and
cellular pp60'(' kinases differed to a lesser extent with respect to inhibition by
adenosine-5'-tetraphosphate, di(guanosine-5')tetraphosphate, and ADP. No sig-
nificant differences were found in the ATP K,m, values of pp60O-"' (0.108 ± 0.048
p.M) and pp60c"'' kinases (0.056 0.012 F.M). These results demonstrate that the
protein kinase activities of viral and cellular pp60r"' are functionally distinguish-
able, particularly on the basis of enhanced sensitivity of the viral enzyme to
inhibition by Pt,P4-di(adenosine-5')tetraphosphate. These functional differences
are likely to be due to differences in the conformation of the active site and may be
important for determining transformation potential.
Cell transformation by Rous sarcoma virus
(RSV) is controlled by a single protein encoded
by the sre gene of the virus (reviewed in refer-
ence 1). The src gene product pp60 -V"'' has been
identified as a 60,000-dalton phosphoprotein that
acts as a protein kinase (4, 7, 13). A very similar
homolog, pp6Oc-rc, is encoded by the genome of
normal, uninfected cells in a wide variety of
animal species (5, 6, 19, 22). pp6Oc'-r( is also a
60,000-dalton phosphoprotein with associated
protein kinase activity (5, 6, 12, 19, 22). Both
protein kinases phosphorylate tyrosine in the
heavy chain of immunoglobulin G (IgG) mole-
cules from rabbits bearing RSV-induced tumors
and in other protein substrates (2, 6-8, 10, 12,
14, 15, 19, 22, 23). The exact molecular details of
how pp60v-src induces transformation are not
understood. Transformation could be the conse-
quence of the 20- to 100-fold elevated levels of
pp60v-src in transformed cells compared with the
levels of pp6Oc-src in normal cells (5, 6, 12).
Alternatively, differences in the activities of
these proteins may lead to transformation in one
case and normal cell growth in the other.
Functional differences in the protein kinase
activities of pp6ov-vr, and pp60cs's have not been
reported, even though the viral and cellular
forms of pp6Osr( can be structurally distin-
guished by several criteria. For example, many
tumor-bearing rabbit (TBR) sera that recognize
pp60v-sr, do not recognize pp6Oc-,rc (6). Addition-
ally, the peptide maps of the immunoprecipitat-
ed proteins show minor differences (5, 6, 12, 19,
22), and although both proteins are phosphory-
lated at serine and tyrosine residues in vivo,
their phosphotyrosine residues are located in
different tryptic peptides (11, 25). Finally, pre-
dicted amino acid sequences show differences in
the carboxy-terminal domains that could be im-
portant for transformation (30). To directly con-
trast the enzymatic activities of pp60c"'' and
pp6Ov-rc, it would be useful to develop inhibitors
of tyrosine-specific protein phosphorylation that
would discriminate between the two proteins.
Recently we showed that P1,P4-di(adenosine-
5')tetraphosphate (Ap4A) inhibits the protein
kinase activity of pp60v-'' (17) that was purified
7,000-fold from the RSV-transformed rat tumor
line RR1022 (16). Ap4A is a nucleotide that is
present in animal cells and has been proposed as
a pleiotypic regulator of cell proliferation (21). In
this paper we report that pp6Oc-rc and pp6Ov-rc
can be functionally discriminated on the basis of
the sensitivity of their protein kinase activities to
inhibition by Ap4A.
MATERIALS AND METHODS
Nucleotides. Sodium Ap2A, ammonium Ap3A, am-
monium Ap4A, lithium Ap5A, ammonium Ap6A, and
other nucleotides were purchased from Sigma Chemi-
cal Co. With the exception of Ap6A, all compounds
appeared pure at the 5% level when analyzed by thin-
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layer chromatography (17). All diadenosine nucleo-
tides were treated with alkaline phosphatase which
was immobilized on polyacrylamide beads (Sigma) as
described previously (17) to hydrolyze any ATP or
ADP that might be present in the samples below the
limit of detection. The concentrations of these and
other nucleotide solutions were determined spectro-
photometrically.
Cells, viruses, and extract preparation. Chick em-
bryo fibroblasts (CEF) were prepared from virus-free,
group specific (gs) antigen-negative embryos (SPA-
FAS, Norwich, Conn.) and were transformed with
RSV-Schmidt-Ruppin subgroup D (RSV-CEF) ob-
tained from H. Hanafusa, Rockefeller University,
New York, N.Y. Cells were grown in Hams FIO
medium with 5% calf serum. Cell extracts were pre-
pared from 80 to 90% confluent cultures of CEF or
confluent RSV-CEF grown on 100-mm tissue culture
dishes. Each plate of cells was washed three times
with 10 mM Tris-hydrochloride (pH 7.4)-150 mM
NaCl-1 mM EDTA-100 Kallikrein inhibitor units of
aprotinin per ml, and the cells were lysed at 4°C in 1 ml
of lysis buffer which contained 20 mM potassium
phosphate (pH 7.1), 1 mM EDTA, 0.5% (wt/vol)
sodium deoxycholate, 1% (vol/vol) Nonidet P-40, 10
mM sodium fluoride, 2 mM dithiothreitol, 150 mM
KCl, and 100 Kallikrein inhibitor units of aprotinin per
ml. After being briefly vortexed, the lysate was clari-
fied at 10,000 x g for 30 min. The resulting cell extract
was stored at -70°C.
Antisera. TBR serum was prepared from rabbits
bearing tumors induced by the Schmidt-Ruppin strain
of RSV by using the method of Brugge and Erikson
(4). Of seven rabbit sera with positive titers for anti-
bodies that recognized pp6O-vr(, only one serum con-
tained antibodies that also recognized pp60c"rc. The
TBR serum that contained antibodies that recognized
both proteins was used in all studies reported here.
Enzymatic parameters for pp60v-sc were confirmed by
using one of the TBR sera that contained antibodies
that only recognized pp60v-rc.
Protein kinase assays. pp60>-"' and pp60cs"( kinases
were assayed in the immunoprecipitate with TBR IgG
as the substrate by using a modification (15) of the
method of Collett and Erikson (7). A 50-,ul amount of
CEF extract (111 pug of protein) or a 10-pul amount of
RSV-CEF extract (22 pug of protein) brought to 50 ,ul
with lysis buffer was incubated with 5 pul ofTBR serum
for 1 h at 4°C. Protein A-Sepharose was added for 30
min to adsorb the immune complexes formed, and the
resulting immunoprecipitates were washed three times
with 50 mM Tris-hydrochloride (pH 7.2)-0.15 M NaCl,
once with 2.5 M KCI-60 mM Tris-hydrochloride (pH
7.2), and once with 40 mM Tris-hydrochloride (pH
7.2)-0 mM MgCI2. The reaction was initiated by the
addition of S p.Ci of [y-32P]ATP (New England Nuclear
Corp.; 2,000 to 4,000 Ci/mmol) in 20 mM Tris-hydro-
chloride (pH 7.2)-5 mM MgCIl5 mM dithiothreitol
and nucleotide inhibitors, where indicated, in a total
solution volume of 35 ,.1. The reaction was carried out
at 37°C for 10 min. The immunoprecipitates were
washed with 20 mM Tris-hydrochloride (pH 7.2-S5
mM MgCI2, and the reaction was terminated by heat-
ing in sodium dodecyl sulfate sample buffer for 2 min
at 95°C. 32P-labeled IgG heavy chains were separated
on 8.5% sodium dodecyl sulfate-polyacrylamide gels
that were then fixed, stained with Coomassie blue, and
dried. The heavy chain regions were excised from the
dried gel, and gel slices were counted for 32P in
Aquasol (Brinkmann Instruments, Inc.). The results of
duplicate determinations were averaged. In some cas-
es the data were confirmed by using pp60vsr( purified
7,000-fold from the rat tumor cell line RR1022 (16).
Determinations of apparent Km. The apparent Km
values for ATP were determined by using the assay
described above with the following modifications.
Immunoprecipitates were incubated with [y-32P]ATP
(0.005 to 1.8 ,uM, 2,900 Ci/mmol) at 37°C for 1 min.
Time course experiments indicated that the reaction
velocity was linear at this time. The reaction was
terminated by heating the samples for 1 min at 95°C.
K,,, values were obtained from plots of duplicate
samples by application of the weighted least-squares
analysis of Wilkinson (28).
RESULTS
To compare pp60vsr and pp60csr kinase
activities for inhibition by Ap4A under identical
conditions, the kinases were immunoprecipitat-
ed from extracts of uninfected CEF and RSV-
CEF by using a TBR serum that recognized both
proteins. Phosphorylation of TBR IgG heavy
chains in the immunoprecipitates was carried
out in the presence of various amounts of Ap4A.
Conditions of antibody excess were employed
in all experiments. Although the amounts of
pp60c-src and pp6Ov-src protein immunoprecipi-
tated were not identical, their sensitivity to
inhibition by Ap4A could be compared by plot-
ting the percent inhibition of activity as a func-
tion of Ap4A concentration. pp6ovsr kinase was
found to be significantly more sensitive to inhibi-
tion by Ap4A than pp6Oc sr, kinase (Fig. 1). The
concentration of Ap4A required for 50% inhibi-
tion of pp6Ov-sr' kinase activity (IC50, 1 ,uM) was
almost 50-fold lower than the concentration re-
quired to inhibit pp6Oc-src (IC50, 46 ,uM) at 50 nM
ATP. The extent of inhibition of pp6vsr` kinase
by Ap4A was not significantly affected by using
a TBR serum that recognized only pp60v-,rc
(IC50, 4 ,uM).
To rule out the possibility that Ap4A was
preferentially degraded by contaminants such as
phosphodiesterases in immunoprecipitates of
CEF extracts, Ap4A at various concentrations
was preincubated with immunoprecipitates from
CEF extracts containing pp6Ocsrc for 10 min at
37°C and transferred to immunoprecipitates
from RSV-CEF extracts containing pp6Ovsr(.
Kinase activity was measured in the immuno-
precipitates. Ap4A that had been preincubated
with the CEF immunoprecipitates inhibited
pp60v-sr, kinase activity with the same effective-
ness (IC50, 1.2 ,uM) as fresh Ap4A (IC50, 1.6 ,uM)
or Ap4A that had been preincubated with im-
munoprecipitates of pp6ov-src prepared from
RSV-CEF extracts (IC50, 1.2 ,uM). As an addi-
tional test of Ap4A degradation, pp6Oc-src and
pp60v-src were immunoprecipitated from an
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FIG. 1. Inhibition of pp60c-sc and pp60v-sr kinase
activities by Ap4A. The phosphorylation of TBR IgG
by pp60c5r (0) and pp60v-s" (0) was measured in
immunoprecipitates in the presence of the indicated
concentrations of Ap4A as described in the text, and
the percent of inhibition of activity was calculated.
The uninhibited activity of pp60vsrc was 85,100 cpm of
32P incorporated into IgG heavy chains under the
conditions of the assay, and for pp6Ocsrc it was 2,700
cpm of 32p.
amount of CEF (111 ,ug) or RSV-CEF extract
(22 ,ug) usually used in the assay and also from
10-fold excess amounts. The washed immuno-
precipitates were incubated with Ap4A (6 mM)
for 10 min at 370C. Samples were chromato-
graphed on polyethyleneimine cellulose thin-
layer sheets with fluorescent indicator in 0.7 M
LiCl-0.02% formic acid (vol/vol) and examined
under UV light. No degradation of Ap4A to
ATP, ADP, AMP, or adenosine was observed in
any sample. A comparison with various amounts
ofADP as standards indicated that any degrada-
tion of Ap4A in the incubation mixture would be
less than 9% of the input Ap4A concentration.
A mixing experiment was carried out to deter-
mine whether the relaxed sensitivity of pp60csrc
to Ap4A inhibition was due to a free substance in
normal uninfected cells that could bind to either
pp60csrc or pp60v-Src and render it less sensitive to
Ap4A (Table 1). The same antiserum was used to
immunoprecipitate pp60v-src and pp60c-sr from
RSV-CEF extracts, CEF extracts, and a mixture
of RSV-CEF and CEF extracts. Kinase activity
was measured in the immunoprecipitates in the
presence of Ap4A at various concentrations.
pp6Ov-src immunoprecipitated from the mixed ex-
tracts was as sensitive to Ap4A inhibition as
pp6Ov-src from the RSV-CEF extract, as seen
from the IC50 values. Thus, the reduced sensitiv-
ity of pp,60csrc to inhibition by Ap4A appears to
be an intrinsic property of the Ap4A binding site
of pp6Osrc molecules.
Related diadenosine nucleotides of general
structure Ap"A (n = 2 to 6) were evaluated as
inhibitors of the protein kinase activities of
pp60c-src and pp60v-src to gain information con-
cerning the molecular dimensions of their Ap4A
binding sites (Fig. 2). The compounds differ only
in the length of the phosphoryl group bridge
linking the two adenosine moieties at the 5'
position. Ap4A and Ap5A inhibited both kinase
activities maximally when present at a single
concentration (100 ,uM). Ap2A, Ap3A, and Ap6A
were less effective. These results imply that the
Ap4A binding sites of both enzymes are similar
and can best accommodate diadenosine nucleo-
tides with greater than three phosphoryl groups.
Other nucleotides structurally related to Ap4A
did not discriminate between the enzymatic ac-
tivities of pp60v-src and pp6Oc-src to the extent
that Ap4A did (Table 2). Adenosine tetraphos-
phate (Ap4) was nearly as effective as Ap4A as
an inhibitor of pp60v-src. However, there was
only a 3- to 4-fold difference in the IC50 values of
Ap4 when the viral enzyme was compared with
the cellular enzyme, in contrast to the 50-fold
difference in IC50 values of Ap4A. Surprisingly,
di(guanosine-5')tetraphosphate was not found to
be an effective inhibitor of either enzyme, indi-
cating a high degree of specificity for the adenine
moiety of Ap4A. Di(guanosine-5')tetraphos-
phate (100 ,uM) inhibited pp6O-src kinase activi-
ty by only 23% and pp60f-src kinase activity by
24%. ADP, which is a product of the kinase
reaction, inhibited both enzymes at low concen-
trations. However, ADP failed to discriminate
between pp60-5sr and pp6Oc-src(. The threefold
difference of observed inhibition by ADP does
not appear to be significant, because an interme-
diate IC50 value (0.22 i,M) was obtained for
TABLE 1. Effect of mixing extracts on Ap4A
inhibitiona
Kinase activity in
Immuno- immunoprecipitates (cpm of 32p in-
precipitate corporated into IgG)b at Ap4A IC50
from: concn: (LM)
OjFM 1 FM 4 ,M 40 ,M
RSV-CEF 28,800 12,900 6,090 1,320 1
CEF 1,530 1,330 970 860 40
RSV-CEF + 23,200 11,160 6,530 1,220 2
CEF
a pp60V-src and pp60" were immunoprecipitated
with the same TBR serum from extracts of RSV-CEF
(17 ,ug of protein), CEF (17 pg of protein), and a
mixture of both extracts (17 ,ug of protein each).
b Kinase activity was measured in immunoprecipi-
tates at 50 nM ATP with various Ap4A concentrations,
as described in the text. Ap4A IC50 values were
determined by plotting the percent of inhibition as a
function of Ap4A concentration, as in Fig. 1.
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FIG. 2. Effect of diadenosine nucleotides on inhibi-
tion of pp604-src and pp60v-sr kinase activities. The
phosphorylation of TBR IgG by pp60c-rc (0) and
pp6&J-src (0) was measured in immunoprecipitates in
the presence of diadenosine nucleotides (100 pLM) as
described in the text, and the percent inhibition of
activity was calculated. The uninhibited activity of
pp60(v-src was 11,100 cpm of 32p incorporated into IgG
heavy chains under the conditions of the assay, and for
pp60c-src it was 450 cpm of 32p.
pp6Ovsr, using different TBR serum. Finally, we
found that neither enzyme was inhibited by
AMP or adenosine (100 FLM).
ATP and Ap4A compete for binding to puri-
fied pp60vsrc probably at the enzyme phospho-
donor site (17). Thus, it was possible that the
different affinities of pp64c-src and pp6Ov-src for
Ap4A reflected different affinities for its ATP
moiety. To address this we determined their
apparent Km values for ATP in the immune
complex protein kinase assay. No significant
differences in the apparent ATP Km values for
the viral and cellular enzyme were found, using
the same antiserum to measure the activity of
both enzymes (Table 2). A different TBR serum,
which contained antibodies that recognized only
pp60VvSrc, gave a Km of 0.040 ± 0.017 ,uM for the
viral enzyme, a value similar to the Km with the
antiserum that recognized both proteins. Km
values for ATP approximated a Km value deter-
mined by using purified pp6Ov-src (0.016 + 0.003
,uM) assayed with TBR IgG in solution rather
than in immunoprecipitates. To the extent that
Km determinations in the immune complex as-
say reflect binding of ATP, the differential sensi-
tivity of pp6cs'rc to inhibition by Ap4A cannot
be accounted for by differential affinities of the
enzymes for ATP. Thus, the second adenosine
moiety of Ap4A appears to provide a unique
binding determinant that discriminates between
the active sites of pp60csrs and pp60vsr".
DISCUSSION
In this paper we report evidence for functional
differences between the active sites of pp60`csrc'
and pp60v-sr, as revealed by a great difference in
sensitivity of these two enzymes to inhibition by
a small molecule, Ap4A. These findings are in
accord with our previous studies which showed
that Ap4A and ATP compete for a common
binding site on the pp6v sr,, molecule that is
most likely to be the phosphodonor site (17).
Similar results have also been recently reported
by Barnekow (A. Barnekow, Biosci. Rep., in
press).
The implications of the results reported here
are limited by the nature of the immune complex
protein kinase assay. It is possible that certain
subpopulations of TBR antibody molecules that
recognize only the viral src protein are responsi-
ble for the difference in sensitivity to Ap4A. On
the other hand, a slight difference in the anti-
body substrates may not significantly affect the
degree of inhibition by Ap4A. For example,
similar concentrations of Ap4A effectively inhib-
it the phosphorylation by pp6Ov-src of the unre-
lated phosphoacceptor substrates tubulin, mi-
crotubule-associated proteins, vinculin, and
TBR IgG (17). These substrates presumably
share a unique tyrosine-containing peptide se-
quence (20) that is recognized by both proteins.
Moreover, two different antibodies used as the
substrate for the viral enzyme gave similar IC50
values for Ap4A and ADP and a similar Km value
for ATP. Nonetheless, it will be important to
confirm the results reported here with purified
pp60c-src when it becomes available or with mono-
clonal antibodies as the substrate. At present,
however, the immune complex kinase assay is
TABLE 2. Effect of nucleotides related to Ap4A on kinase activity of pp6f'-rC and pp60c-src
Kinasea AP4A IC,o (pLM) AP4 IC,o (>.M) Gp4Gb IC50 ADP IC,,O (AM) ATP K,,, (>M)(FM)
pp6Ov-src 1 2.5 >100 0.34 0.108 + 0.048
pp60c-src 46 9 >100 0.13 0.056 + 0.012
a pp6fjv-src and pp60c-src were immunoprecipitated with the same TBR serum from extracts of RSV-CEF and
CEF, and assays were carried out as described in the text.
b Gp4G, Di(guanosine-5') tetraphosphate.
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the only means of comparing the activities of
pp60v-src and pp60csrc under the same conditions.
One model for the inhibition of pp6Osrc kinases
by Ap4A is that Ap4A binds in the active site
owing to its resemblance to ATP during catalytic
transfer to a tyrosine residue on the substrate
protein. Presumably the y-phosphoryl group of
ATP moves out to a position on the enzyme
molecule equivalent to the fourth position of
Ap4A during transfer to tyrosine. In support of
this model, Ap4A and only those diadenosine
nucleotides with greater than three phosphoryl
residues were found to be effective inhibitors.
The reduced sensitivity of the cellular enzyme to
inhibition by Ap4A appears to be due to a
reduced affinity for the second adenosine moi-
ety, because pp6Oc srC and pp6Ov-sr( were similar
in their affinities for Ap4, ATP, and ADP. Differ-
ences in the primary structures of the two en-
zymes have been identified at their carboxyl
termini (26) that could alter the conformation of
the active site in such a way as to affect the
binding of the Ap4A molecule. Alternatively
these conformational changes could result from
differences in phosphorylation (11, 25) or palmi-
tylation (9, 24).
The possibility that Ap4A is a regulator of
pp6jsrc activity in vivo should be considered.
Clearly Ap4A is present in animal cells at micro-
molar concentrations and increases during cell
proliferation (21). Assuming that pp6Ocsrc plays
a role in growth control of normal cells, Ap4A
may participate in the regulation of pp60csrc
activity during cell cycle progression, possibly
as a feedback inhibitor. In transformed cells,
Ap4A may not reach an inhibitory concentra-
tion. In this regard it is interesting that an
enzyme that specifically degrades Ap4A, a dia-
denosine tetraphosphatase, has recently been
isolated from human leukemia cells in which it is
present in high amount (18).
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